Prognostic Nomogram on Clinicopathologic Features and Serum Uric Acid for Precancerous Lesions and Gastric Cancer
暂无分享,去创建一个
Huanbai Xu | Nengguang Fan | Ying Chen | Qi-fa Zhang | Shan-shan Tang | Ziyu Song | Jianzhong Xu | Xin Xie | Yihang Zhang | Yong-hui Peng | Chen-Wei Fu
[1] R. Safaralizadeh,et al. Helicobacter pylori‐related risk predictors of gastric cancer: The latest models, challenges, and future prospects , 2020, Cancer medicine.
[2] Yiling Song,et al. A Novel Nomogram Integrated with Inflammation-Based Factors to Predict the Prognosis of Gastric Cancer Patients , 2020, Advances in Therapy.
[3] Kyunga Kim,et al. Lack of Association between Past Helicobacter pylori Infection and Diabetes: A Two-Cohort Study , 2019, Nutrients.
[4] Liang Zhou,et al. Pretreatment Serum Uric Acid as an Efficient Predictor of Prognosis in Men with Laryngeal Squamous Cell Cancer: A Retrospective Cohort Study , 2019, Oxidative medicine and cellular longevity.
[5] I. Derweesh,et al. Rising Serum Uric Acid Level Is Negatively Associated with Survival in Renal Cell Carcinoma , 2019, Cancers.
[6] J. Fransen,et al. Crystal-proven gout patients have an increased mortality due to cardiovascular diseases, cancer, and infectious diseases especially when having tophi and/or high serum uric acid levels: a prospective cohort study , 2019, Clinical rheumatology.
[7] S. Zhuang,et al. Relationship between serum uric acid and clustering of cardiovascular disease risk factors and renal disorders among Shanghai population: a multicentre and cross-sectional study , 2019, BMJ Open.
[8] A. Lam. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours , 2017, Endocrine Pathology.
[9] J. Pisegna,et al. Autoimmune atrophic gastritis: current perspectives , 2017, Clinical and experimental gastroenterology.
[10] Chao Lu,et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. , 2016, Journal of hepatology.
[11] A. Digklia,et al. Advanced gastric cancer: Current treatment landscape and future perspectives. , 2016, World journal of gastroenterology.
[12] B. Sheu,et al. Metabolic Interaction of Helicobacter pylori Infection and Gut Microbiota , 2016, Microorganisms.
[13] R. Liu,et al. Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis , 2015, BioMed research international.
[14] Z. Soltani,et al. Potential Role of Uric Acid in Metabolic Syndrome, Hypertension, Kidney Injury, and Cardiovascular Diseases: Is It Time for Reappraisal? , 2013, Current Hypertension Reports.
[15] R. Wright,et al. Contribution of uric acid to cancer risk, recurrence, and mortality , 2012, Clinical and Translational Medicine.
[16] L. See,et al. Increased risk of cancer among gout patients: a nationwide population study. , 2012, Joint, bone, spine : revue du rhumatisme.
[17] N. Linder,et al. Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma. , 2012, Gynecologic oncology.
[18] B. Longo-Mbenza,et al. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. , 2007, International journal of cardiology.
[19] K. Pfeiffer,et al. Serum uric acid and risk of cancer mortality in a large prospective male cohort , 2007, Cancer Causes & Control.
[20] H. Çelik,et al. Insulin resistance in H pylori infection and its association with oxidative stress. , 2006, World journal of gastroenterology.
[21] E. Elkin,et al. Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.
[22] C. Nishida,et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.
[23] M. Liu,et al. Prevalence of Helicobacter pylori infection and its association with lipid profiles. , 2016, Bratislavske lekarske listy.
[24] [Chinese guidelines on prevention and treatment of dyslipidemia in adults]. , 2007, Zhonghua xin xue guan bing za zhi.